Back to Search
MARK TURCO, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1386606697Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
D0057131(MD)
Research & Publications (20)
Ferritin heavy chain (FHC) is up-regulated in papillomavirus-associated urothelial tumours of the urinary bladder in cattle.
PMID 19596355·J Comp Pathol·2010
7-preclinical
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
PMID 19628185·JACC Cardiovasc Interv·2009
4-observational
Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation.
PMID 19425053·Catheter Cardiovasc Interv·2009
6-review
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
PMID 19496901·J Interv Cardiol·2009
4-observational
Evidence for modulation of BAG3 by polyomavirus JC early protein.
PMID 19282432·J Gen Virol·2009
8-other
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
PMID 19463432·JACC Cardiovasc Interv·2009
8-other
Statistical methodology used in the TAXUS ATLAS Trial.
PMID 19147050·J Am Coll Cardiol·2009
4-observational
Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy.
PMID 18821011·Breast Cancer Res Treat·2009
8-other
BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.
PMID 18821563·J Cell Physiol·2009
8-other
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
PMID 19463308·JACC Cardiovasc Interv·2008
4-observational
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
PMID 19016469·Catheter Cardiovasc Interv·2008
4-observational
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
PMID 18420096·J Am Coll Cardiol·2008
4-observational
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
PMID 19463387·JACC Cardiovasc Interv·2008
4-observational
Identification of a synaptosome-associated form of BAG3 protein.
PMID 18818513·Cell Cycle·2008
7-preclinical
High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation.
PMID 18614613·Hum Reprod·2008
7-preclinical
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
PMID 18556716·Eur Heart J·2008
4-observational
Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells.
PMID 18469860·Oncogene·2008
8-other
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
PMID 19463293·JACC Cardiovasc Interv·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15215 SHADY GROVE RD, SUITE 306
ROCKVILLE, MD 20850 - Phone
- (301) 990-0040
Quick Facts
- NPI
- 1386606697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile